127 related articles for article (PubMed ID: 17495951)
1. Epigenetic control of the S100A6 (calcyclin) gene expression.
Leśniak W; Słomnicki ŁP; Kuźnicki J
J Invest Dermatol; 2007 Oct; 127(10):2307-14. PubMed ID: 17495951
[TBL] [Abstract][Full Text] [Related]
2. Binding and functional characteristics of two E-box motifs within the S100A6 (calcyclin) gene promoter.
Leśniak W; Kuźnicki J
J Cell Biochem; 2006 Apr; 97(5):1017-24. PubMed ID: 16288473
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis.
Zhu L; Kohda F; Nakahara T; Chiba T; Tsuji G; Hachisuka J; Ito T; Tu Y; Moroi Y; Uchi H; Furue M
J Dermatol Sci; 2013 Dec; 72(3):311-9. PubMed ID: 23993025
[TBL] [Abstract][Full Text] [Related]
4. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
6. S100A6 expression in keratinocytes and its impact on epidermal differentiation.
Graczyk A; Leśniak W
Int J Biochem Cell Biol; 2014 Dec; 57():135-41. PubMed ID: 25450463
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
8. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.
Wang XH; Zhang LH; Zhong XY; Xing XF; Liu YQ; Niu ZJ; Peng Y; Du H; Zhang GG; Hu Y; Liu N; Zhu YB; Ge SH; Zhao W; Lu AP; Li JY; Ji JF
Am J Pathol; 2010 Aug; 177(2):586-97. PubMed ID: 20581057
[TBL] [Abstract][Full Text] [Related]
9. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
10. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
11. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
13. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
15. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression.
Larsson L; Thorbert-Mros S; Rymo L; Berglundh T
Eur J Oral Sci; 2012 Feb; 120(1):14-20. PubMed ID: 22288916
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
Kusumoto T; Hamada T; Yamada N; Nagata S; Kanmura Y; Houjou I; Kamikawa Y; Yonezawa S; Sugihara K
J Oral Maxillofac Surg; 2012 Jun; 70(6):1486-94. PubMed ID: 21821326
[TBL] [Abstract][Full Text] [Related]
17. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
[TBL] [Abstract][Full Text] [Related]
18. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
Rehman I; Cross SS; Azzouzi AR; Catto JW; Deloulme JC; Larre S; Champigneuille J; Fromont G; Cussenot O; Hamdy FC
Br J Cancer; 2004 Aug; 91(4):739-44. PubMed ID: 15280928
[TBL] [Abstract][Full Text] [Related]
19. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
20. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
Nakagawachi T; Soejima H; Urano T; Zhao W; Higashimoto K; Satoh Y; Matsukura S; Kudo S; Kitajima Y; Harada H; Furukawa K; Matsuzaki H; Emi M; Nakabeppu Y; Miyazaki K; Sekiguchi M; Mukai T
Oncogene; 2003 Dec; 22(55):8835-44. PubMed ID: 14647440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]